Previous study reported that increased IL-10 in patients with lymphoproliferative disorder causes elevated triglycerides, low LDL-C and HDL-C deficiency, and IL-10 is thus a potent modulator of lipoprotein levels [25]. This evidence concerns the gene IL10 and lymphoproliferative syndrome.